Pharmacological treatment of paraphilias with a focus on antidepressants

Journal of Sex and Marital Therapy

Volumn 24, Issue 4, 1998, Pages 241-254

  Balon, Richard ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTIDEPRESSANT AGENT; BUSPIRONE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; LITHIUM; PHENOTHIAZINE DERIVATIVE; SEROTONIN AGONIST; SERTRALINE;

ARTICLE; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HORMONAL THERAPY; HUMAN; SEXUAL DEVIATION;

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; HUMANS; MALE; PARAPHILIAS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0031739646     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239808403960     Document Type: Article

References (62)

1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed, Washington, DC, Author, 1994.
2. Johnson BR, Becker JV: Sexual wickedness, Psychiatric Annals, 27:634-637, 1997.
3. Rasmussen SA: Commentary—obsessive compulsive spectrum disorders, J Clin Psychiatry, 55:89-91, 1994.
4. Kafka MP, Prentky RA: Preliminary observations of DSM-III-R Axis 1 comorbidity in men with paraphilias and paraphilia-related disorders, J Clin Psychiatry, 55:481-487, 1994.
5. Kafka MP, Prentky R: A comparative study of nonparaphilic sexual addictions and paraphilias in men, J Clin Psychiatry, 53:345-350, 1992.
6. Fedoroff PJ, Peyser C, Franz ML, Folstein SE: Sexual disorders in Huntington’s disease, J Neuropsychiatry & Clin Neurosci, 6:147-153, 1994.
7. Wise TN: Fetishism—etiology and treatment: A review from multiple perspectives, Comp Psychiatry, 26:249-257, 1985.
8. Kilmann PR, Sabalis RF, Gearing II, ML, Bukstel LH, Scovern AW: The treatment of sexual paraphilias: A review of the outcome research, J Sex Res, 75:193-252, 1982.
9. Bradford J Mc DW: Research on sex offenders. Recent trends, Psych Clin Am, 6:715-731, 1983.
10. Cooper AJ: Progesterons in the treatment of male sexual offenders: A review, Can J Psychiatry, 37:73-79, 1986.
11. Heller CG, Laidlaw WM, Harvey HT, Nelson DL: Effects of progestional compounds on the reproductive processes of the human male, Ann NY Acad Sci, 77:649-665, 1958.
12. Thibault F, Cordier B, Kuhn J-M: Gonadotropin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment, Psychoneuroendocrinology, 27:411-419, 1996.
13. Bancroft J, Tennent G, Loucas K, Cass J: The control of deviant sexual behavior by drugs: I. Behavioural changes following Oestrogens and Anti-Androgens, Brit J Psychiatry, 725:310-315, 1974.
14. Bradford JMW, Pawlak A: Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias, Arch Sex Behav, 22:383-402, 1993.
15. Hucker S, Langevin R, Bain J: A double blind trial of sex drive reducing medication in pedophiles, Ann Sex Res, 7:227-242, 1988.
16. Cooper AJ, Sadhu S, Losztyn S, Cernovsky Z: A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles, Can J Psychiatry, 37.687-693, 1992.
17. Bradford J Mc DW, Pawlak A: Sadistic homosexual pedophilia: Treatment with cyproterone acetate: A single case study, Can J Psychiatry, 32:22-30, 1987.
18. Thibault F, Cordier B, Kuhn J-M: Effects of a long-lasting gonadotropin hormone-releasing hormone agonist in six cases of severe male paraphilia, Acta Psychiatr Scand, 87:445-450, 1993.
19. Rousseau L, Couture M, Dupont A, Labrie F, Couture N: Effect of combined androgen blockade widi LHRH agonist and flutamide in one severe case of male exhibitionism, Can J Psychiatry, 35:338-341, 1990.
20. Dickey R: The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist, Can J Psychiatry, 37:567-569, 1992.
21. Rich SS, Ovsiew F: Leuprolide acetate for exhibitionism in Huntington’ disease. Movement disorders, 9:353-357, 1994.
22. Bartholomew AA: Some side effects of thioridazine, Med J Australia, 7:57, 1964.
23. Litkey LJ, Feniczy P: An approach to die control of homosexual practices, Int J Neuropsychiatry 3:20-23, 1967.
24. Bardiolomew AA: A long-term phenothiazine as a possible agent to control deviant sexual behavior, Am J Psychiatry, 724:917-923, 1968.
25. Field LH: Benperidol in die treatment of sexual offenders, Med Sci Law, 73:195, 1973.
26. Ward N: Successful lithium treatment of transvestism associated with manic depression, J Nerv Mental Dis, 767:204-206, 1975.
27. Bartova D, Nahunek K, Svesdca J, Hajnova R: Comparative study of prophylactic lithium and diediylstilbestrol in sexual deviants, Activ Nerv Sup (Praha), 27:163-164, 1979.
28. Cesnik JA, Coleman E: Use of lidiium carbonate in the treatment of autoerotic asphyxia, Am JPsychother, 43:273-286, 1989.
29. Coleman E, Cesnik J: Skoptic syndrome: The treatment of an obsessional gender dysphoria widi lithium carbonate and psychouierapy, Am J Psychother, 44:204-217, 1990.
30. Coleman E, Cesnik J, Moore A-M, Dwyer SM: An exploratory study of the role of psychotropic medication in the treatment of sex offenders, J Offender Rehab, 18:75-88, 1992.
31. Pearson HJ: Paraphilias, impulse control, and serotonin, J Clin Psychopharmacol, 70:233, 1990.
32. Fedoroff JP: Serotonergic drug treatment of deviant sexual interests, Ann Sex Res, 6.105-121, 1993.
33. Messiha FS: Fluoxetine: A spectrum of clinical applications and postulates of underlying mechanism, Neurosci & Behav Rev, 27:385-396, 1993.
34. Bradford JMW: The role of serotonin in the future of forensic psychiatry, Bull Am. Acad Psychiatry Law, 24:57-72, 1996.
35. Snaith RP, Collins SA: Five exhibitionists and a method of treatment, Brf Psychiatry, 138:126-150, 1981.
36. Jorgensen VT: Cross-dressing successfully treated with fluoxetine, NY State J Med, 90:566-567, 1990.
37. Shabry FR: Cross-dressing successfully treated with fluoxetine. A letter to the editor. NY State J Med, 91:171, 1991.
38. Bianchi MD: Fluoxetine treatment of exhibitionism, Am J Psychiatry, 147:1089-1090, 1990.
39. Kafka MP: Successful treatment of paraphilic coercive disorder (a rapist) widi fluoxetine hydrochloride, Br f Psychiatry, 158:844-847.
40. Kafka MP: Successful antidepressant treatment of nonparaphilic sexual addiction and paraphilias in men, J Clin Psychiatry, 52:60-65, 1991.
41. Lorefice LS: Fluoxetine treatment of a fetish, J Clin Psychiatry, 52:41, 1991.
42. Kerbeshian J, Burd L: Tourette syndrome and recurrent paraphilic masturbatory fantasy, Can J Psychiatry, 36:155-157, 1991.
43. Perilstein RD, Lipper S, Friedman LJ: Three cases of paraphilias responsive to fluoxetine, J Clin Psychiatry, 52:169-170, 1991.
44. Emmanuel NP, Lydiard RB, Ballenger JC: Fluoxetine treatment of voyeurism, Am J Psychiatry, 148:950, 1991.
45. Rubey R, Brady KT, Norris GT: Clomipramine treatment of sexual preoccupation. J Clin Psychopharmacol, 13:158-159, 1993.
46. Leo RJ, Kim KY: Clomipramine treatment of paraphilias in elderly demented patients, J Geri Psychiatry Neurol, 5:123-124, 1995.
47. Zohar J, Kaplan Z, Benjamin J: Compulsive exhibitionism successfully treated with fluvoxamine: A controlled case study, J Clin Psychiatry, 55:86-88, 1994.
48. Bourgeois JA, Klein M: Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia, J Clin Psychopharmacol, 16:257-258, 1996.
49. Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon B, Liebowitz MR, Klein DF: Serotonergic medication for sexual obsessions, sexual addictions, and paraphilias, J Clin Psychiatry, 53:267-271, 1992.
50. Greenberg DM, Bradford JMW, Curry S, O’Rourke A: A comparison of the treatment of paraphilias with diree serotonin reuptake inhibitors: A retrospective study, Bull Am Acad Psychiatry Law, 24:525-532, 1996.
51. Jancin B: Serzone shows promise for paraphilia tx, Clin Psychiatry News, Dec:18, 1997.
52. Kafka MP, Prentky R: Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men, J Clin Psychiatry, 53:351-358, 1992.
53. Kafka MP: Sertraline pharmacodierapy for paraphilias and paraphilia-related disorders: An open trial. Ann Clin Psychiatry, 6:189-195, 1994.
54. Kruesi MJP, Fine S, Valladares L, Phillips Jr, RA, Rappaport JL: Paraphilias: A double-blind crossover comparison of clomipramine versus desipramine, Arch Sex Beh, 21:587-593, 1992.
55. Fedoroff JP: Buspirone hydrochloride in the treatment of transvestic fetishism, J Clin Psychiatry, 49:408-409, 1988.
56. Fishbain DA: Buspirone and transvestic fetishism, J Clin Psychiatry, 50:436-437, 1989.
57. Fedoroff JP: Dr. Fedoroff replies, J Clin Psychiatry, 50:437, 1989.
58. Fedoroff JP: Buspirone hydrochloride in die treatment of an atypical paraphilia. Arch Sex Behav 21:401-406, 1992.
59. Pearson HJ, Marshall WL, Barbaree HE, Southmayd S: Treatment of a compulsive paraphiliac with buspirone, Ann Sex Res 5:239-246, 1992.
60. Stevenson RWD, Solyom L: The aphrodisiac effect of fenfluramine: Two case reports of a possible side effects to die use of fenfluramine in die treatment of bulimia, J Clin Psychopharmacol, 10:69-71, 1990.
61. Rodenburg M, Sheldon L, Owen JA: Sexual disinhibition with L-tryptophan, Can J Psychiatry, 37:666-667, 1992.
62. McCormick S, Olin J, Brotman AW: Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients, J Clin Psychiatry, 51:383-384, 1990.